INDIA

Tamil Nadu allows Chinese Covid vaccine makers to bid unlike Mumbai
IANS -
​​​​​​​"We are allowing every product (vaccine) as long as it is approved by the World Health Organisation (WHO) and licensed by the Drugs Controller General of India (DGCI)," a senior official told IANS.On the other hand, the Brihanmumbai Municipal Corporation in its one crore vaccine dose tender has disqualified companies located in countries sharing borders with India from participating in the bid.
Remdesivir allocated till May 23 to States/UTs: Union Minister Sadananda Gowda
IANS -
Considering the requirement of Remdesivir in every state and ensuring its adequate availability, Union Minister of Chemicals & Fertilisers D.V Sadananda Gowda on Sunday announced the allocation of Remdesivir and said substantial increase has been made in overall production and allocation of the drug, crucial in treatment of Covid patients.
Rajeev Satav was upcoming leader with much potential: PM Modi
IANS -
"Anguished by the passing away of my friend from Parliament, Shri Rajeev Satav Ji. He was an upcoming leader with much potential. Condolences to his family, friends and supporters. Om Shanti," Modi said. Rajeev Satav, passed away in a hospital in New Delhi after a 23-day long battle with Covid-19, party officials said here on Sunday.
One dead, trees uprooted as Cyclone Tauktae causes disruption in Goa
IANS -
Sheetal Patil, 34, succumbed to injuries in the beach village of Anjuna after she was hit by a coconut tree which was uprooted in the cyclonic winds. According to Power Minister Nilesh Cabral, feeder electrical lines from other states have been damaged, which has resulted in a severe power outage.
Who is in, Who is out, only Pinarayi Vijayan knows
IANS -
Even with the Indian Medical Association's Kerala chapter has requested that with Covid continuing to surge, it would be better to have it virtually, the swearing in has been fixed to be held outdoors at the Central Stadium, a stone's throw from the seat of power of the State Secretariat, but with Covid protocols in force.
Covaxin demonstrates protection against new variants
IANS -
Bharat Biotech's Covaxin retained neutralising activity against emerging variants of coronavirus, as per a new study. A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested including B1617 and B117, first identified in India and the UK, respectively.
Cyclonic Tauktae very likely to intensify in next 24 hrs
IANS -
The cyclone is very likely to move north-northwestwards and reach Gujarat coast in the evening hours of May 17 and cross Gujarat coast between Porbandar and Mahuva (Bhavnagar district) around May 18 early morning, said the National Weather Forecasting Centre of the India Meteorological Department (IMD).
India records 3.11 lakh new Covid cases, 4,077 deaths
IANS -
In the past 24 days, India's daily Covid tally has plateaued over the three-lakh mark and over 3,000 casualties for 18 days. On Wednesday, India recorded 4,205 fresh Covid deaths, the highest ever, while on May 7, the country had recorded its highest ever cases of 4,14,188. India's total tally of Covid-19 cases now stands at 2,46,84,077 with 36,18,458 active cases and 2,70,284 deaths so far.
India will have 51.6 crore vaccine doses by end of July: Harsh Vardhan
IANS -
Vardhan reviewed the public health response to Covid-19 and the progress of vaccination with Uttar Pradesh, Madhya Pradesh, Andhra Pradesh and Gujarat. These states are depicting a higher growth rate in the number of daily cases, rise in positivity, high mortality and saturation of healthcare capacity.
PM Modi holds high-level meeting to review preparedness on Cyclone 'Tauktae'
IANS -
The Prime Minister directed senior officers to take every possible measure to ensure that people are safely evacuated by the state governments and to ensure maintenance of all essential services such as power, telecommunications, health, drinking water and are restored immediately in the event of damages caused to them.
Advertisement